Showing results (151-160 of 176) with videos related to
Sort By:
Pageof 18
JAMA Network Open|September 26, 2023
Longitudinal Recovery Following Repetitive Traumatic Brain InjuryLeila L Etemad, John K Yue, Jason Barber, et al.Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetesDenise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.Journal of Neurosurgery|March 15, 2024
Performance of the IMPACT and CRASH prognostic models for traumatic brain injury in a contemporary multicenter cohort: a TRACK-TBI studyJohn K Yue, Young M Lee, Xiaoying Sun, et al.The Journal of Biological Chemistry|June 7, 2007
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese miceRuojing Yang, Denise M Wilcox, Deanna L Haasch, et al.Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.Pain|February 24, 2026
Longitudinal pain intensity and interference symptomatology in mild traumatic brain injury: a TRACK-TBI studyChristine J Gotthardt, Jason K Barber, Shawn R Eagle, et al.Injury|February 11, 2026
Neuroworsening from a normal Glasgow Coma Scale Motor Score in the emergency department is an early predictor of neurosurgical intervention, hospital outcomes, and longitudinal disability in traumatic brain injury: A TRACK-TBI StudyJohn K Yue, Allen Y Fu, Mahmoud M Elguindy, et al.Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.Molecular Cell|September 21, 2021
Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPKChe-Chia Hsu, Xian Zhang, Guihua Wang, et al.British Journal of Haematology|May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United StatesMarcus Geer, Emily Roberts, Maryann Shango, et al.Pageof 18